Zymar: Clinical Trials

2 trials of Zymar, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 terminated. 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 32Completed 1, Terminated 1

Follow Zymar: new trials by email Literature Review of Zymar trials Research Report on Zymar

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy of the Ophthalmic Pazufloxacin 0.6% for Bacterial Conjunctivitis, Compared to Gatifloxacin 0.3%.
Pazufloxacin, Zymar - Conjunctivitis, Bacterial
Phase 3TerminatedLaboratorios Sophia S.A de C.V.462018-10-012021-08-24
Non-Inferiority of Gatifloxacin/Prednisolone Association vs Isolated Administration in Prevention of Ocular Infection/Inflammation
0.3% gatifloxacin and 1.0% prednisolone acetate association, isolated 0.3% gatifloxacin and 1.0% prednisolone acetate - Ocular Infection and Inflammation
Phase 3CompletedFederal University of São Paulo1012009-01-012018-03-21

Conditions studied

Conjunctivitis, Bacterial (1)  ·  Eye Infections (1)  ·  Inflammation (1)

Sponsors

Federal University of São Paulo (1)  ·  Laboratorios Sophia S.A de C.V. (1)

Countries

Brazil (1)  ·  Mexico (1)